🇺🇸 FDA
Patent

US 6703016

Apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines

expired A61KA61K2039/5154A61K38/00

Quick answer

US patent 6703016 (Apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines) held by I.D.M. Immuno-Designed Molecules expires Mon Mar 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
I.D.M. Immuno-Designed Molecules
Grant date
Tue Mar 09 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/5154, A61K38/00, A61K39/0011, A61P